FDA Warning Letter — Revive Rx LLC dba Revive Rx Pharmacy

Case 709509 — FEI 3016710945

The FDA took a Warning Letter action against Revive Rx LLC dba Revive Rx Pharmacy on September 22, 2025 (Houston, TX). The action was issued by CDER and concerns drugs products. This facility has 3 recent FDA inspections on record.

Action Details

Facility
Revive Rx LLC dba Revive Rx Pharmacy
Date
September 22, 2025
Fiscal Year
2025
Product Type
Drugs
Center
CDER
Location
Houston, TX (United States)